Should androgen deprivation therapy and other systemic treatments be used in men with prostate cancer and a rising PSA post-local treatments?

Biochemical recurrence is an evolving space in prostate cancer, with increasing multidisciplinary involvement. Androgen deprivation therapy has shown proof of its value in complementing salvage radiotherapy in high-risk biochemical relapsing patients; ongoing trials aim to further refine this treatm...

Descripción completa

Detalles Bibliográficos
Autores principales: Patrikidou, Anna, Zilli, Thomas, Baciarello, Giulia, Terisse, Safae, Hamilou, Zineb, Fizazi, Karim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8543684/
https://www.ncbi.nlm.nih.gov/pubmed/34707693
http://dx.doi.org/10.1177/17588359211051870

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8543684/
https://www.ncbi.nlm.nih.gov/pubmed/34707693
http://dx.doi.org/10.1177/17588359211051870

Ejemplares similares